Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Alirocumab
Regeneron UK Limited
Atherosclerosis
1 trial -
Alirocumab
Regeneron UK Limited
Myocardial Infarction
2 trials -
Alirocumab 150 MG/ML subcutaneous injection
Regeneron UK Limited
Saphenous Vein Graft Atherosclerosis
1 trial -
Alirocumab SAR236553
Regeneron UK Limited
Hypercholesterolemia
1 trial -
Alirocumab, Placebo product for REGN727
The George Institute
Cardiac allograft vaculopathy in recent heart transplant recipients
1 trial -
Allopurinol Tablet 300 mg
Hospital Authority, Hong Kong
Kidney Calculi
1 trial -
Alogliptin
Takeda
Diabetes Mellitus, Type 2
6 trials -
Amiodarone Hikma 50 mg/ml soluzione iniettabile, BUPISEN 5 mg/ml soluzione iniettabile, Lidocaina Kabi 20 mg/ml soluzione iniettabile
Fondazione Telethon ETS
electrical storm
1 trial -
Amiodarone hydrochloride 200 mg tablets
The George Institute
Persistent atrial fibrillation
1 trial -
Amoxicilina/Ácido clavulánico NORMON 1.000 mg/200 mg polvo para solución inyectable y para perfusión EFG, Amoxicilina/Ácido clavulánico NORMON 875 mg/125 mg comprimidos recubiertos con película EFG
The George Institute
Complicated acute appendicitis
1 trial -
Amoxicillin 500 mg film-coated tablets, Placebo amoxicillin capsules 500mg
Disc Medicine
non-specific low back pain
1 trial -
Anti-Platelet Drugs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Unstable Angina
3 trials -
Apixaban
Pfizer
Atrial Fibrillation
1 trial -
Arctic Front Advance Cardiac CryoAblation system
Rhythm Pharmaceuticals Netherlands B.V.
Paroxysmal Atrial Fibrillation
1 trial -
Arm A: ABC+3TC+NNRTI
United Therapeutics Europe Ltd
Human Immunodeficiency Virus
1 trial -
Aspirin + Clopidogrel + Rivaroxaban
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
Atezolizumab
Hoffmann-La Roche
Carcinoma, Non-Small-Cell Lung
1 trial -
Azilsartan
Takeda
Essential Hypertension With Stable Angina and Dyslipidemia
1 trial -
Azilsartan
Takeda
Essential Hypertension Complicated by Type 2 Diabetes Mellitus
1 trial -
BENZATHINE BENZYLPENICILLIN , LINEZOLID
MEDA Pharma GmbH & Co. KG
Syphilis
1 trial -
BEYONTTRA 356 mg film-coated tablets
Bayer Australia Ltd
Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
1 trial -
BILINDA GYNIAL 0,03 mg/2 mg Filmtabletten, Selina Gynial 0,03 mg/0,15 mg Filmtabletten
Pari Pharma GmbH
Hormonal contraception
1 trial -
BOTOX 200 UNITÉS ALLERGAN, poudre pour solution injectable, DYSPORT 500 UNITES SPEYWOOD, poudre pour solution injectable
Ipsen
Upper limb spasticity (ULS) of any aetiology (in US and France) or post- stroke ULS (in Canada)
1 trial -
Babaodan oral capsule
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources